BlackRock, Inc. 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
BLACKROCK INC BLK |
5,382,184 7.500% |
2,057,446 (+61.88%) |
Filing |
| 2023-02-07 12:59 pm Purchase |
2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
BLACKROCK INC BLK |
3,324,738 5.300% |
3,324,738 (New Position) |
Filing |